Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2018 Filed Dec 6, 2018 23:14 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 3,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001418 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC |
Scott Christopher K.CFO & Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,856 Underlying: Common Stock · 2,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC |
Scott Christopher K.CFO & Secretary
|
Tax withholdingCommon Stock | 719 | $26.78 | $19,254.82 |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,334 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC |
Scott Christopher K.CFO & Secretary
|
Exercise / conversionCommon Stock | 2,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 22:59 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001413 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 22:59 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001413 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,926 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 22:59 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001413 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 22:53 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001411 · form4.xml · derivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 3,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 22:53 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 3,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001411 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 16:56 UTC |
Casey Francis X.VP of Reg and Qual Assurance
|
SaleCommon Stock | 47,948 | $29.12 | $1,396,274.53 |
DisclosureSEC source: 0000898432-18-001012 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,831 F2 · price: This transaction was executed in multiple trades at prices ranging from $28.15 to $30.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 16:56 UTC |
Casey Francis X.VP of Reg and Qual Assurance
|
SaleCommon Stock | 7,052 | $30.51 | $215,129.02 |
DisclosureSEC source: 0000898432-18-001012 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,779 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.25 to $30.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:33 UTC |
McCreery John KChief Operating Officer
|
SaleCommon Stock | 3,861 | $27.10 | $104,633.10 |
DisclosureSEC source: 0000898432-18-000904 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:41 UTC |
ALLEN MONTY KDirector
|
SaleCommon Stock | 4,347 | $27.04 | $117,526.36 |
DisclosureSEC source: 0000898432-18-000906 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 F1 · price: This transaction was executed in multiple trades at prices ranging from $27.00 to $27.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,907 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 9 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,907 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
|
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | SaleCommon Stock | 3,907 | $25.76 | $100,663.46 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 6 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $25.50 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
|
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | GrantCommon Stock | 3,907 | $1.48 | $5,782.36 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 5 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,008 Read SEC document |
|
| August 08, 2018 Filed Aug 10, 2018 16:33 UTC |
McCreery John KChief Operating Officer
|
SaleCommon Stock | 3,139 | $27.55 | $86,479.45 |
DisclosureSEC source: 0000898432-18-000904 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,486 Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:37 UTC |
Waldman Louis S.Controller
|
SaleCommon Stock | 35,000 | $26.06 | $911,925.00 |
DisclosureSEC source: 0000898432-18-000905 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Louis Waldman Trust Disclosed balance after: 25,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 66,046 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 8 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,907 Underlying: Common Stock · 66,046 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
|
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | SaleCommon Stock | 66,046 | $26.03 | $1,719,078.31 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 4 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F2 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
|
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | GrantCommon Stock | 66,046 | $1.48 | $97,748.08 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,147 Read SEC document |
|
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,297 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 7 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,953 Underlying: Common Stock · 26,297 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
|
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | SaleCommon Stock | 26,297 | $26.16 | $687,905.85 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
|
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | GrantCommon Stock | 26,297 | $1.48 | $38,919.56 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,398 Read SEC document |
|
| August 03, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,957 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,775 Underlying: Common Stock · 6,957 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
SaleCommon Stock | 6,957 | $24.20 | $168,342.01 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F2 · price: This transaction was executed in multiple trades at prices ranging from $24.10 to $24.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
GrantCommon Stock | 6,957 | $0.93 | $6,470.01 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,325 Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 6 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 2,188 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 5,000 shares, was granted on 12/15/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 5 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · derivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,188 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 8,750 shares, was granted on 12/13/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
SaleCommon Stock | 7,662 | $23.80 | $182,349.47 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.75 to $23.975. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
GrantCommon Stock | 2,500 | $9.84 | $24,600.00 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,662 Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:04 UTC |
Nardi Steven M.VP MANUFACTURING
|
GrantCommon Stock | 4,376 | $1.48 | $6,476.48 |
DisclosureSEC source: 0000898432-18-000887 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,162 Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 93,043 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,732 Underlying: Common Stock · 93,043 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
SaleCommon Stock | 93,043 | $24.00 | $2,232,641.22 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.90 to $24.325. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 21:36 UTC |
JOHNSON BRENTExec. VP Sales and Marketing
|
GrantCommon Stock | 93,043 | $0.93 | $86,529.99 |
DisclosureSEC source: 0000898432-18-000888 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,411 Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 17:57 UTC |
Kennedy JonathanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,458 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000758 · form4.xml · derivative · entry 2 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,458 Underlying: Common Stock · 2,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 27, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on June 27, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On June 27, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on June 27, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 17:57 UTC |
Kennedy JonathanDirector
|
Exercise / conversionCommon Stock | 2,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000758 · form4.xml · nonDerivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 17:00 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
SaleCommon Stock | 35,000 | $18.50 | $647,524.50 |
DisclosureSEC source: 0000898432-18-000707 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,831 F1 · price: This transaction was executed in multiple trades at prices ranging from $18.50 to $18.575. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:52 UTC |
Waldman Louis S.Controller
|
SaleCommon Stock | 5,221 | $18.19 | $94,987.22 |
DisclosureSEC source: 0000898432-18-000605 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 02, 2018 Filed May 4, 2018 15:11 UTC |
ALLEN MONTY KDirector
|
SaleCommon Stock | 1,899 | $17.94 | $34,068.06 |
DisclosureSEC source: 0000898432-18-000580 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,972 F1 · price: This transaction was executed in multiple trades at prices ranging from $17.80 to $18.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2018 Filed May 1, 2018 21:15 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000558 · form4.xml · derivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 27, 2018 Filed May 1, 2018 21:15 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000558 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:11 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000407 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644 Underlying: Common Stock · 2,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:11 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 2,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000407 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 16, 2018 Filed Mar 19, 2018 19:22 UTC |
Waldman Louis S.Controller
|
SaleCommon Stock | 29,169 | $13.84 | $403,599.79 |
DisclosureSEC source: 0000898432-18-000356 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Louis Waldman Trust Disclosed balance after: 60,000 Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 23:00 UTC |
Susi Roger E.Director · CEO, President, Chairman · 10% owner
|
PurchaseCommon Stock | 1,000 | $13.85 | $13,850.00 |
DisclosureSEC source: 0000898432-18-000358 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 19:22 UTC |
Waldman Louis S.Controller
|
SaleCommon Stock | 831 | $13.75 | $11,426.25 |
DisclosureSEC source: 0000898432-18-000356 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Louis Waldman Trust Disclosed balance after: 89,169 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 01:05 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,563 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000007 · form4.xml · derivative · entry 4 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. F3 · derivative.expiration_date: This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 01:05 UTC |
ALLEN MONTY KDirector
|
GrantCommon Stock | 6,563 | $1.48 | $9,713.24 |
DisclosureSEC source: 0000898432-18-000007 · form4.xml · nonDerivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,871 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.